Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients

von Negrouk, Anastassia, Lacombe, Denis, Cardoso, Fatima, Morin, Franck, Carrasco, Eva, Maurel, Joan, Maibach, Rudolf, Aranda, Enrique, Marais, Richard, Stahel, Rolf A
Veröffentlicht in ESMO Open (2017)

Phase II study assessing the benefit of cisplatin re-introduction (stop-and-go strategy) in patients with advanced non-squamous non-small cell lung cancer: the IFCT-1102 BUCiL stud...

von Bennouna, Jaafar, Barlesi, Fabrice, Do, Pascal, Dumont, Patrick, Cadranel, Jacques, Debieuvre, Didier, Hilgers, Werner, Molinier, Olivier, Quoix, Elisabeth, Raimbourg, Judith, Langlais, Alexandra, Morin, Franck, Souquet, Pierre-Jean
Veröffentlicht in ESMO Open (2018)

Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation...

von Dubois, Fatéméh, Keller, Maureen, Hoflack, Julien, Maille, Elodie, Antoine, Martine, Westeel, Virginie, Bergot, Emmanuel, Quoix, Elisabeth, Lavolé, Armelle, Bigay-Game, Laurence, Pujol, Jean-Louis, Langlais, Alexandra, Morin, Franck, Zalcman, Gérard, Levallet, Guénaëlle
Veröffentlicht in Cancers (Basel) (2019)

MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial

von Maille, Elodie, Brosseau, Solenn, Hanoux, Vincent, Creveuil, Christian, Danel, Claire, Bergot, Emmanuel, Scherpereel, Arnaud, Mazières, Julien, Margery, Jacques, Greillier, Laurent, Audigier-Valette, Clarisse, Moro-Sibilot, Denis, Molinier, Olivier, Corre, Romain, Monnet, Isabelle, Gounant, Valérie, Langlais, Alexandra, Morin, Franck, Levallet, Guénaëlle, Zalcman, Gérard
Veröffentlicht in Br J Cancer (2019)

MSH2/BRCA1 expression as a DNA-repair signature predicting survival in early–stage lung cancer patients from the IFCT-0002 Phase 3 Trial

von Levallet, Guénaëlle, Dubois, Fatéméh, Fouret, Pierre, Antoine, Martine, Brosseau, Solenn, Bergot, Emmanuel, Beau-Faller, Michèle, Gounant, Valérie, Brambilla, Elisabeth, Debieuvre, Didier, Molinier, Olivier, Galateau-Sallé, Françoise, Mazieres, Julien, Quoix, Elisabeth, Pujol, Jean-Louis, Moro-Sibilot, Denis, Langlais, Alexandra, Morin, Franck, Westeel, Virginie, Zalcman, Gérard
Veröffentlicht in Oncotarget (2016)

Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab

von Herbreteau, Guillaume, Langlais, Alexandra, Greillier, Laurent, Audigier-Valette, Clarisse, Uwer, Lionel, Hureaux, José, Moro-Sibilot, Denis, Guisier, Florian, Carmier, Delphine, Madelaine, Jeannick, Otto, Josiane, Souquet, Pierre-Jean, Gounant, Valérie, Merle, Patrick, Molinier, Olivier, Renault, Aldo, Rabeau, Audrey, Morin, Franck, Denis, Marc G, Pujol, Jean-Louis
Veröffentlicht in J Clin Med (2020)

Overall survival with crizotinib and next-generation ALK inhibitors in ALK-positive non-small-cell lung cancer (IFCT-1302 CLINALK): a French nationwide cohort retrospective study

von Duruisseaux, Michaël, Besse, Benjamin, Cadranel, Jacques, Pérol, Maurice, Mennecier, Bertrand, Bigay-Game, Laurence, Descourt, Renaud, Dansin, Eric, Audigier-Valette, Clarisse, Moreau, Lionel, Hureaux, José, Veillon, Remi, Otto, Josiane, Madroszyk-Flandin, Anne, Cortot, Alexis, Guichard, François, Boudou-Rouquette, Pascaline, Langlais, Alexandra, Missy, Pascale, Morin, Franck, Moro-Sibilot, Denis
Veröffentlicht in Oncotarget (2017)